The diagnosis of LCAT deficiency was established with a combination of clinical and pathological findings.<h4>Conclusions</h4>Currently renal prognosis is poor but conservative management with ACE inhibitors and lipid lowering therapy in addition to steroids has been shown to retard progression to end-stage renal disease. Here, LCAT is linked to stage 5 chronic kidney disease.